| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 192.487 | 208.958 | 226.065 | 246.744 | 189.817 | 185.845 | 223.570 | 227.105 | 289.544 | 349.954 |
| Total Income - EUR | 192.844 | 209.091 | 226.240 | 246.960 | 190.476 | 186.840 | 226.719 | 227.163 | 289.553 | 349.958 |
| Total Expenses - EUR | 171.830 | 194.351 | 219.387 | 237.913 | 187.999 | 182.777 | 210.064 | 221.856 | 284.183 | 335.944 |
| Gross Profit/Loss - EUR | 21.014 | 14.740 | 6.852 | 9.047 | 2.477 | 4.063 | 16.654 | 5.307 | 5.370 | 14.014 |
| Net Profit/Loss - EUR | 17.555 | 12.333 | 3.433 | 6.578 | 606 | 2.575 | 14.387 | 3.308 | 2.764 | 4.565 |
| Employees | 11 | 11 | 12 | 12 | 9 | 8 | 8 | 9 | 9 | 9 |
Check the financial reports for the company - Analimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 110.273 | 110.740 | 109.533 | 103.119 | 96.921 | 92.490 | 87.817 | 90.541 | 86.452 | 115.736 |
| Current Assets | 23.055 | 26.225 | 26.890 | 39.161 | 25.806 | 20.860 | 31.837 | 28.418 | 40.092 | 34.631 |
| Inventories | 406 | 299 | 1.260 | 1.547 | 4.019 | 2.619 | 1.117 | 8.565 | 10.058 | 5.428 |
| Receivables | 11.600 | 11.921 | 20.828 | 15.623 | 14.926 | 4.205 | 12.736 | 19.066 | 24.872 | 20.859 |
| Cash | 11.049 | 14.005 | 4.802 | 21.991 | 6.861 | 14.036 | 17.985 | 786 | 5.162 | 8.344 |
| Shareholders Funds | 65.007 | 76.677 | 78.812 | 83.944 | 82.925 | 83.928 | 96.454 | 97.719 | 97.963 | 99.770 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 68.321 | 60.288 | 57.611 | 58.336 | 39.803 | 29.422 | 23.200 | 21.239 | 28.581 | 50.597 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Analimed Srl